Daylight ActThis bill allows states to observe daylight saving time year-round. (States may already choose to observe standard time year-round.)

Health Care Providers Safety Act of 2023 This bill authorizes the Department of Health and Human Services to award grants to health care providers for security services and other expenses related to physical security and cybersecurity.

This joint resolution nullifies the final rule titled Energy Conservation Program: Energy Conservation Standards for Commercial Water Heating Equipment, which was submitted by the Department of Energy on October 6, 2023. The rule adopts more stringent energy conservation standards for commercial water heating equipment under the Energy Policy and Conservation Act in order to achieve more energy savings.

Defund Planned Parenthood Act of 2025

Guarding America’s Stoves Act or the GAS Act This bill prohibits federal agencies from banning the use or sale of gas-burning stoves.

Barriers and Regulatory Obstacles Avoids Deployment of Broadband Access and Needs Deregulatory Leadership Act or the BROADBAND Leadership ActThis bill limits the authority of a state or locality to regulate the placement, construction, or modification of telecommunications service facilities.States and localities may not discriminate in such regulations among providers of telecommunications services, including based on the technology used to provide services. In addition, states and localities may not regulate in a manner that effectively prohibits the provision or improvement of interstate or intrastate telecommunications services.However, states and localities may charge reasonable, cost-based fees (1) to review requests to place, construct, or modify telecommunications service facilities; or (2) for the use of property owned or managed by the state or locality for the placement, construction, or modification of those facilities.States or localities must respond to requests to place, construct, or modify facilities and for other related actions by specified deadlines. Such deadlines may only be tolled by a mutual agreement between the applicant and the state or locality, or in the event that the application is incomplete and requires a supplemental submission. If a decision is not made by the deadline, the request is deemed to be approved. Further, denials of requests must be made in writing, supported by evidence, and promptly released to the public.A person adversely affected by an alleged violation of these provisions may petition the courts for expedited review of the actions of the state or locality. 

Health Care Prices Revealed and Information to Consumers Explained Transparency Act or the Health Care PRICE Transparency Act This bill provides statutory authority for requirements for hospitals and health insurance plans to disclose certain information about the costs for items and services. Specifically, hospitals must publish in their list of standard charges certain rates negotiated with insurers, discounts for cash payments, and billing codes. Further, hospitals generally must publish the standard charges for the services provided by the hospital that may be scheduled in advance. Additionally, insurance plans must publish the in-network and out-of-network charges for covered items and services and the negotiated prices for covered prescription drugs. Plans must provide a tool for consumers to search for this cost information. Consumers also may request additional information about the costs of specific items or services under their plans.

People-Centered Assistance Reform Effort Act or the People CARE Act This bill establishes the People-Centered Assistance Reform Effort Commission within the legislative branch to review federal means-tested welfare programs. Means-tested welfare programs are those designed to specifically provide assistance exclusively to low-income Americans. The commission shall review all federal means-tested programs, excluding various specified programs such as the Social Security benefits program, Medicare, and Department of Veterans Affairs-administered programs. The commission's review shall cover topics including (1) ways to make the benefits programs more efficient and streamlined, (2) opportunities to reduce costs by contracting with private entities or delegating to states, (3) any programs that should be subject to discretionary appropriations, and (4) changes to allow caseworkers to have a holistic view of the beneficiary. The commission shall report its findings to Congress, and the report shall include proposed legislation to carry out the commission's recommendations. The Speaker of the House of Representatives and the Senate majority leader shall introduce the proposed legislation in their respective chambers. The proposed legislation shall be considered under certain expedited procedures, such as limitations on debate.

Title X Abortion Provider Prohibition Act This bill prohibits the Department of Health and Human Services (HHS) from awarding family planning grants to entities that perform abortions or provide funding to other entities that perform abortions. To receive a grant, an entity must certify it will refrain from those activities during the grant period. The bill provides exceptions for abortions (1) in cases of rape or incest; or (2) when the life of the woman is in danger due to a physical disorder, injury, or illness. It also exempts hospitals unless they provide funds to non-hospital entities that provide abortions. HHS must report annually on this prohibition.

Standardizing Thresholds Of Penalties for Fentanyl Act or the STOP Fentanyl Act This bill reduces the drug quantity thresholds that trigger a mandatory minimum prison term for a defendant who manufactures, distributes, imports, exports, or possesses with intent to distribute fentanyl. The bill also creates enhanced criminal penalties for certain violations involving fentanyl that was imported along the U.S.-Mexico border. Specifically, the bill reduces from 400 to 5 grams the fentanyl quantity and from 100 to 0.05 grams the fentanyl analogue quantity that trigger a mandatory minimum prison term for high-level first-time or repeat offenders. It also reduces from 40 to 0.5 grams the fentanyl quantity and from 10 to 0.005 grams the fentanyl analogue quantity that trigger a mandatory minimum prison term for low-level first-time or repeat offenders. Additionally, the bill creates enhanced mandatory minimum prison terms for importing or exporting fentanyl that was imported along the U.S.-Mexico border.

Daylight Act This bill allows states to observe daylight savings time year-round. (States may already choose to observe standard time year-round.)

Robo Calls Off Phones Act or the Robo COP Act This bill directs the Federal Trade Commission to revise the do-not-call registry provisions of the Telemarketing Sales Rule to prohibit politically-oriented recorded message telephone calls to numbers listed on that registry. A politically-oriented recorded message telephone call is an outbound telephone call that plays a recorded message that (1) promotes, advertises, campaigns, or solicits donations for or against a political candidate or regarding a political issue; or (2) uses a political candidate's name.

Pandemic is Over Act This bill terminates the COVID-19 public health emergency that was declared on January 31, 2020, on the date of the bill's enactment.

Preserving Choice in Vehicle Purchases Act

This bill nullifies certain changes made by the Food and Drug Administration (FDA) to dispensing requirements for mifepristone. (Mifepristone is a drug that is approved to end pregnancies through 10 weeks gestation when used in conjunction with the drug misoprostol. The procedure is often referred to as medication abortion or the abortion pill.) The FDA regulates the use of mifepristone through the Mifepristone Risk Evaluation and Mitigation Strategy (REMS) program. The program requires health care providers to comply with certain requirements in order to prescribe or dispense mifepristone to end a pregnancy; the program previously included an in-person dispensing requirement that required mifepristone to be directly dispensed to patients in clinics, medical offices, or hospitals. During the COVID-19 public health emergency, the FDA temporarily stopped enforcing the in-person dispensing requirement, which allowed mail-order pharmacies to fill and dispense mifepristone prescriptions. In January 2023, the FDA modified program requirements so as to (1) remove the in-person dispensing requirement, and (2) require pharmacies to be certified in the program in order to dispense mifepristone. The modifications allow retail pharmacies, after receiving certification, to dispense mifepristone pursuant to prescriptions that are written by program-certified prescribers. The bill nullifies the January 2023 changes and prohibits any similar changes in the future.